EUVIMEDScopri EUVIMED
Multizentrische StudieBeobachtungsstudieOpen access · CC BY-NC-ND 4.0

Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib

Lucía Pérez-Lamas, Adrián Segura Díaz, Elvira Mora Casterá, Marta Hidalgo Soto, Antonio Paz Coll, Natalia De Las Heras, Montse Cortes, Patricia Vélez Tenza, Magdalena Sierra Pacho, Alicia Senin Magan, Anna Angona, Carlos Cervero and 6 more

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05906-6 ↗

At a glance

Multizentrische Studie in Annals of Hematology, 2024. Written by Lucía Pérez-Lamas and 17 co-authors. Institution: Hospital Universitario Puerta de Hierro, Madrid, Spain. Major MEDLINE topics: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Protein Kinase Inhibitors. Cited 3 times so far (Crossref); 24 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Abstract non disponibile.

Subjects

MeSH terms (MEDLINE)

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveProtein Kinase InhibitorsHumansMaleFemaleMiddle AgedRetrospective StudiesAgedAdultDrug Resistance, NeoplasmTreatment FailureTreatment OutcomePyridazinesTyrosine Kinase InhibitorsImidazolesNiacinamidePyrazoles

Author keywords

AsciminibChronic myeloid leukemiaConventional tyrosine kinase inhibitorsIntoleranceReal world settingResistance

Substances

Protein Kinase InhibitorsasciminibponatinibPyridazinesTyrosine Kinase InhibitorsImidazolesNiacinamidePyrazoles

Authors and institutions

  • Hospital Universitario Puerta de Hierro, Madrid, Spain.
  • Hospital Universitario de Gran Canaria Doctor Negrín, Gran Canaria, Spain.
  • Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Hospital Universitario Vall d´Hebron, Barcelona, Spain.
  • Hospital Universitario Puerto Real, Puerto Real, Spain.
  • Hospital Universitario de León, León, Spain.

Cite

APA

Pérez-Lamas, L., Díaz, A. S., Casterá, E. M., Soto, M. H., Coll, A. P., De Las Heras, N., Cortes, M., Tenza, P. V., Pacho, M. S., Magan, A. S., Angona, A., Cervero, C., de Paz, R., Cuenca, A. S., Santaliestra, M., Marín, J. L., Casado, L. F., & García-Gutiérrez, V. (2024). Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib. Annals of Hematology. https://doi.org/10.1007/s00277-024-05906-6

Vancouver

Pérez-Lamas L, Díaz AS, Casterá EM, Soto MH, Coll AP, De Las Heras N, et al. Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib. Annals of Hematology. 2024. doi:10.1007/s00277-024-05906-6

BibTeX
@article{PrezLamas2024,
  author = {Pérez-Lamas, Lucía and Díaz, Adrián Segura and Casterá, Elvira Mora and Soto, Marta Hidalgo and Coll, Antonio Paz and De Las Heras, Natalia and Cortes, Montse and Tenza, Patricia Vélez and Pacho, Magdalena Sierra and Magan, Alicia Senin and Angona, Anna and Cervero, Carlos and de Paz, Raquel and Cuenca, Araceli Salamanca and Santaliestra, Marta and Marín, Javier López and Casado, Luis Felipe and García-Gutiérrez, Valentín},
  title = {Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05906-6}
}
Start for free →